glp-1 leptin Partial Reduction: An Emerging Weight Loss Paradigm: Trends in Endocrinology & Metabolism Lotte Bjerre Knudsen: The Scientist

Weeks 9 through 12 (second escalation): Another dose increase, still once daily

For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission

Do not leave your medication in a hot car, near a window with direct sunlight, or in checked luggage during air travel (cargo holds can reach extreme temperatures)

From 2004 to 2009, an analysis of the database revealed a six-fold increase in pancreatitis incidents linked to the DPP-4 inhibitor sitagliptin and the GLP-1 mimetic exenatide, the first two GLP-1-based medications marketed in the US [51]